Aerocrine buys bankrupt airway tech rival
This article was originally published in Clinica
Executive Summary
Swedish airway disease specialist Aerocrine has settled litigation with its rival Apieron by purchasing the US firm as part of an auction held as a result of Apieron’s bankruptcy.